The ”Competition Law Treatment of Joint Ventures” with Neil Campbell, Renata Fonseca and Sonia Kuester Pfaffenroth
A comparative dialogue between Neil Campbell (Partner at McMillan), Renata Fonseca (Partner at Mattos Filho), and Sonia Kuester Pfaffenroth (Partner at Arnold & Porter), on the subject of the book "Competition Law Treatment of Joint Ventures", published by Concurrences. Our guests continue the discussion into the first multi-jurisdictional survey dedicated exclusively to the competition law treatment of joint ventures across 22 jurisdictions. The survey considers critical issues and questions that businesses and their advisers face when dealing with JV transactions in light of merger control and substantive antitrust laws, in order to provide an up-to-date and comprehensive overview of the state of the law. Explore the full scope of their work and gain insights into this important field of antitrust, by visiting the book’s page on Concurrences. Watch the video version of this episode here. Follow us on Bluesky and join the Concurrences page on Linkedin to receive updates on our next podcast episodes. 1. US Federal Trade Commission, The US FTC and DOJ jointly announce the withdrawal of the Antitrust Guidelines for Collaborations Among Competitors, 12 December 2024. 2. Kenneth Schwartz, Rita Sinkfield Belin, Joseph F. Ciani-Dausch, The US FTC issues amendments to its pre-merger notification form under the Hart-Scott-Rodino Act, 10 October 2024. 3. Brazilian Competition Authority, The Brazilian Competition Authority conditionally approves a 14-year extension term for the activities of an existing joint venture that provides video production and other services for the media sector (SBT / Record / RedeTV), 13 septembre 2023. 4. Anna Huttenlauch, Carolina Vidal, The Brazilian Competition Authority clears a landmark joint venture for the development of sustainability measurement software between leading traders of agricultural commodities (Cargill / Louis Dreyfus / ADM), 21 June 2023. 5. Eileen M. Cole, Anna Aryankalayil, Craig Falls, The US DOJ withdraws policy statements in the healthcare industry to signal increased scrutiny on mergers, joint ventures, group purchasing and information sharing, 3 February 2023.